Hepatitis E in Germany-an under-reported infectious disease
Standard
Hepatitis E in Germany-an under-reported infectious disease. / Pischke, Sven; Behrendt, Patrick; Bock, Claus-Thomas; Jilg, Wolfgang; Manns, Michael P; Wedemeyer, Heiner.
in: DTSCH ARZTEBL INT, Jahrgang 111, Nr. 35-36, 01.09.2014, S. 577-583.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Hepatitis E in Germany-an under-reported infectious disease
AU - Pischke, Sven
AU - Behrendt, Patrick
AU - Bock, Claus-Thomas
AU - Jilg, Wolfgang
AU - Manns, Michael P
AU - Wedemeyer, Heiner
PY - 2014/9/1
Y1 - 2014/9/1
N2 - BACKGROUND: At least 17% of the population in Germany has been infected with the hepatitis E virus (HEV); thus, HEV infections are more frequent than was previously assumed. However, fewer than 500 HEV infections were reported to the Robert Koch Institute in 2013.METHOD: Review of pertinent literature retrieved by a selective search in PubMed.RESULTS: Persons living in Germany generally acquire hepatitis E infection within the country by consuming infected and undercooked pork; in rare cases, hepatitis E infections are imported from the tropics. HEV can be transmitted via blood products, blood transfusions, and organ transplantation. More than 99% of HEV infections are asymptomatic and self-limiting, but there are also severe cases with acute liver failure. Immunosuppressed persons can develop chronic HEV infection, potentially leading, within a few years, to liver cirrhosis with life-threatening sequelae. Moreover, HEV infection may be associated with extrahepatic manifestations such as Guillain-Barré syndrome. In two retrospectively evaluated case series, ribavirin was found to be active against HEV and can be used to treat either acute or chronic HEV infection.CONCLUSION: Hepatitis E must be considered in the differential diagnosis of elevated hepatic enzyme levels and of systemic and neurological conditions of uncertain origin. The infection is usually self-limiting but can take a severe course in immunosuppressed persons. In such cases, ribavirin can be used as an antiviral treatment.
AB - BACKGROUND: At least 17% of the population in Germany has been infected with the hepatitis E virus (HEV); thus, HEV infections are more frequent than was previously assumed. However, fewer than 500 HEV infections were reported to the Robert Koch Institute in 2013.METHOD: Review of pertinent literature retrieved by a selective search in PubMed.RESULTS: Persons living in Germany generally acquire hepatitis E infection within the country by consuming infected and undercooked pork; in rare cases, hepatitis E infections are imported from the tropics. HEV can be transmitted via blood products, blood transfusions, and organ transplantation. More than 99% of HEV infections are asymptomatic and self-limiting, but there are also severe cases with acute liver failure. Immunosuppressed persons can develop chronic HEV infection, potentially leading, within a few years, to liver cirrhosis with life-threatening sequelae. Moreover, HEV infection may be associated with extrahepatic manifestations such as Guillain-Barré syndrome. In two retrospectively evaluated case series, ribavirin was found to be active against HEV and can be used to treat either acute or chronic HEV infection.CONCLUSION: Hepatitis E must be considered in the differential diagnosis of elevated hepatic enzyme levels and of systemic and neurological conditions of uncertain origin. The infection is usually self-limiting but can take a severe course in immunosuppressed persons. In such cases, ribavirin can be used as an antiviral treatment.
U2 - 10.3238/arztebl.2014.0577
DO - 10.3238/arztebl.2014.0577
M3 - SCORING: Zeitschriftenaufsatz
C2 - 25249359
VL - 111
SP - 577
EP - 583
JO - DTSCH ARZTEBL INT
JF - DTSCH ARZTEBL INT
SN - 1866-0452
IS - 35-36
ER -